Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas.

Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Abstract Text:

Céline Pinheiro,Adhemar Longatto-Filho,Cristovam Scapulatempo,Luísa Ferreira,Sandra Martins,Luc Pellerin,Mesquita Rodrigues,Venancio A F Alves,Fernando Schmitt,Fátima Baltazar,

Tumour cells are known to be highly glycolytic, thus producing high amounts of lactic acid. Monocarboxylate transporters (MCTs), by promoting the efflux of the accumulating acids, constitute one of the most important mechanisms in the maintenance of tumour intracellular pH. Since data concerning MCT expression in colorectal carcinomas (CRC) are scarce and controversial, the present study aimed to assess the expressions of MCT1, 2, and 4 in a well characterized series of CRC and assess their role in CRC carcinogenesis. CRC samples (126 cases) were analyzed for MCT1, MCT2, and MCT4 immunoexpression and findings correlated with clinico-pathological parameters. Expression of all MCT isoforms in tumour cells was significantly increased when compared to adjacent normal epithelium. Remarkably, there was a significant gain of membrane expression for MCT1 and MCT4 and loss of plasma membrane expression for MCT2 in tumour cells. Plasma membrane expression of MCT1 was directly related to the presence of vascular invasion. This is the larger study on MCT expression in CRC and evaluates for the first time its clinico-pathological significance. The increased expression of these transporters suggests an important role in CRC, which might justify their use, especially MCT1 and MCT4, as targets in CRC drug therapy.

Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Publishing Authors By Initials

C Pinheiro,A Longatto-Filho,C Scapulatempo,L Ferreira,S Martins,L Pellerin,M Rodrigues,VA Alves,F Schmitt,F Baltazar,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Virchows Archiv : an international journal of path

VOLUME: 452

Page Numbers: 139-46

Journal Abbreviation: Virchows Arch.

ISSN: 0945-6317

DAY: 10

MONTH: 01

YEAR: 2008

Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9423843

Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas.

AFFILIATION: Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Virchows Arch

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas Related Publications

• Ascariasis in children and the response to hexylresorcinol.
• Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas.
• Subcutaneous histamine versus topiramate in migraine prophylaxis: a double-blind study.
• The potential of the case-control method for rapid epidemiological assessment.